Cullinan Therapeutics Newsroom

Cullinan Therapeutics Analyst Ratings

BenzingaJun 3 06:11 ET

Cullinan Therapeutics Analyst Ratings

BenzingaMay 24 06:57 ET

HC Wainwright Adjusts Price Target on Cullinan Oncology to $28 From $29, Maintains Buy Rating

MT NewswiresMay 16 12:07 ET

Cullinan Therapeutics Analyst Ratings

BenzingaMay 16 08:27 ET

Cullinan Therapeutics Analyst Ratings

BenzingaMay 1 05:51 ET

Cullinan Oncology Analyst Ratings

BenzingaApr 17 12:04 ET

Cullinan Oncology Analyst Ratings

BenzingaApr 16 12:56 ET

Cullinan Oncology Analyst Ratings

BenzingaApr 15 08:12 ET

Cullinan Oncology Analyst Ratings

BenzingaMar 14 12:44 ET

Cullinan Oncology Analyst Ratings

BenzingaFeb 15 08:49 ET

JonesTrading Initiates Coverage On Cullinan Oncology With Buy Rating, Announces Price Target of $22

BenzingaOct 6, 2023 05:50 ET

Cullinan Oncology Analyst Ratings

BenzingaOct 6, 2023 05:49 ET

HC Wainwright & Co. Reiterates Buy on Cullinan Oncology, Lowers Price Target to $34

BenzingaAug 11, 2023 13:10 ET

Cullinan Oncology Analyst Ratings

BenzingaAug 11, 2023 13:09 ET

Cullinan Oncology Analyst Ratings

BenzingaAug 9, 2023 10:28 ET

Analyst Ratings for Cullinan Oncology

BenzingaJul 7, 2023 08:04 ET

HC Wainwright & Co. Reiterates Buy on Cullinan Oncology, Maintains $49 Price Target

BenzingaJul 7, 2023 06:05 ET

HC Wainwright & Co. Reiterates Buy on Cullinan Oncology, Maintains $49 Price Target

BenzingaJun 5, 2023 06:30 ET

HC Wainwright & Co. Reiterates Buy on Cullinan Oncology, Maintains $49 Price Target

BenzingaMay 26, 2023 06:12 ET

HC Wainwright Adjusts Price Target on Cullinan Oncology to $49 From $50, Maintains Buy Rating

MT NewswiresMay 12, 2023 07:12 ET